Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | FGF7 |
| Upstream (Parents) |
|---|
| (<<) CASP2 → FGF7 |
| (<<) CAV1 → FGF7 |
| (<<) CLDN5 → FGF7 |
| (<<) G0S2 → FGF7 |
| (<<) GNG11 → FGF7 |
| (<<) GRK5 → FGF7 |
| (<<) HS2ST1 → FGF7 |
| (<<) KCTD12 → FGF7 |
| (<<) KREMEN2 → FGF7 |
| (<<) PDE2A → FGF7 |
| (<<) PPAP2A → FGF7 |
| (<<) RORA → FGF7 |
| (<<) TNXB → FGF7 |
| (<<) TUBA1C → FGF7 |
| (<<) VAC14 → FGF7 |
| Downstream (Children) |
|---|
| FGF7 → ARSD (>>) |
| FGF7 → CLEC2B (>>) |
| FGF7 → EFEMP1 (>>) |
| FGF7 → IL1R1 (>>) |
| FGF7 → MAP3K9 (>>) |
| FGF7 → NGFR (>>) |
| FGF7 → PLA2G4D (>>) |
| FGF7 → PROCR (>>) |
| FGF7 → SCN4B (>>) |
